Director/PDMR Shareholding
4 June 2026
VENTURE LIFE GROUP PLC
("Venture Life", "VLG" or the "Company")
Director/PDMR Shareholding
Venture Life (AIM: VLG), a recognised leader in proactive longevity, health innovation and global commercialisation within the global consumer healthcare sector, announces that Paul McGreevy, Non-Executive Chairman, purchased 88,273 ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares") on 3 June 2026 at a volume-weighted average price of 62.3 pence per Ordinary Share.
Following the purchase, Mr McGreevy beneficially holds 1,052,098 Ordinary Shares representing approximately 0.82 per cent. of the Company's issued share capital.
For further information, please contact:
Venture Life Group PLC
+44 (0) 1344 578004
Jerry Randall, Chief Executive Officer
Daniel Wells, Chief Financial Officer
Cavendish Capital Markets Limited (Nomad and Broker)
+44 (0) 20 7720 0500
Stephen Keys / George Lawson / Joe Smith (Corporate Finance)
Michael Johnson (Sales)
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on commercialising products for the global self-care market. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally. In the UK, Ireland and the USA these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.
The Company makes the following disclosure in accordance with article 19(3) of the Market Abuse Regulation:
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Paul McGreevy
2
Reason for the notification
a)
Position/status
Non-Executive Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Venture Life Group plc
b)
LEI
213800S8CZUPLAB2KC70
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 0.3p each in Venture Life Group plc
GB00BFPM8908
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
Price
Volume
61.6 pence
8,105
61.9 pence
8,066
61.9 pence
8,066
63.8 pence
15,663
62.0 pence
48,373
d)
Aggregated information
- Aggregated volume
- Price
88,273 Ordinary Shares purchased at a volume-weighted average price of 62.3 pence.
e)
Date of the transaction
3 June 2026
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHFFFVLRAIVIIR
